Dong Zhe, Wang Qiqi, Yu Shicheng, Liu Jianjun, Zhang Hui, Huang Fei, Yao Hongyan
Chinese Center for Disease Control and Prevention, Beijing, China.
China CDC Wkly. 2022 Mar 18;4(11):220-225. doi: 10.46234/ccdcw2022.051.
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: China is a country with a high burden of tuberculosis (TB). However, the evaluation of TB burden is usually based on traditional epidemiological indicators, and disability-adjusted life year (DALY) is rarely applied.
WHAT IS ADDED BY THIS REPORT?: In China, the number of DALYs caused by TB in 2019 was estimated to be 1.36 million, and the age-standardized rate (ASR) was 86.46/100,000. The DALYs of TB decreased significantly from 1990 to 2019, with the largest decline from 2001 to 2010. The burden is higher among men than women, and the highest among the elderly.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: Application of DALYs can reflect the damage in health to China's residents caused by tuberculosis. In the future, we should strengthen research, monitor years lived with disability (YLDs), and reduce the burden of the elderly and men. Cost-effective analysis based on DALYs should be conducted to provide a scientific basis for decision-making.
关于该主题已知的信息有哪些?:中国是结核病负担较高的国家。然而,结核病负担的评估通常基于传统流行病学指标,伤残调整生命年(DALY)很少被应用。
本报告补充了哪些内容?:在中国,2019年结核病导致的伤残调整生命年数估计为136万,年龄标准化率为86.46/10万。1990年至2019年期间,结核病的伤残调整生命年数显著下降,2001年至2010年下降幅度最大。男性的负担高于女性,老年人中负担最高。
对公共卫生实践有何启示?:伤残调整生命年的应用可以反映结核病对中国居民健康造成的损害。未来,我们应加强研究,监测失能生存年数(YLD),减轻老年人和男性的负担。应基于伤残调整生命年进行成本效益分析,为决策提供科学依据。